… ’ knowledge of their anticoagulation therapy that … develop and validate a knowledge
instrument that can be used in assessing anticoagulation knowledge related to all the available oral …

… develop and validate an instrument to assess patient knowledge regarding oral anticoagulation
… The Oral Anticoagulation Knowledge (OAK) test was administered to subjects on …

… that is reduced with oral anticoagulation. When deciding to initiate anticoagulation, clinicians
… Although the decision to prescribe oral anticoagulants is straightforward for certain patients, …

… anticoagulants have been developed and introduced in clinical care, including the parenteral
direct thrombin inhibitor argatroban [1] and direct oral anticoagulants (… oral anticoagulants …

… oral anticoagulants (DOAC) and clinical outcomes, mostly because of the lack of validated
… The aim of this study was to develop and validate a questionnaire to self-assess knowledge …

… The objective of this pilot study was to develop and validate a Chinese oral anticoagulant
knowledge tool that is applicable to all oral anticoagulants. As part of this pilot validation study, …

… anticoagulants are an integral part of the treatment. Edoxaban (EDX) is an oral anticoagulant
… determination in tablets are developed and validated using capillary zone electrophoresis (…

… Direct oral anticoagulants are widely used to treat and … concentrations of direct oral
anticoagulants are necessary in certain … The direct oral anticoagulants and internal standards …

… to patients on Direct Oral Anticoagulants (DOACs), with existing risk scores inadequately
predicting ICH risk in these patients. We aim to develop and validate a predictive model for ICH …

… have been reported in the anticoagulation arena. The purpose of this study was to develop
the Anticoagulation Knowledge Assessment (AKA) … Managing oral anticoagulant therapy …